首页> 外文OA文献 >The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling

【2h】

The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling

机译：通过建模的白细胞介素-6和C反应蛋白的时间过程预测佐剂化疗后乳腺癌患者的发热中性粒细胞减少症的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ida Netterberg; Mats O. Karlsson; Elisabet I. Nielsen; Angelica L. Quartino; Henrik Lindman; Lena E. Friberg;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling [J] . Netterberg Ida, Karlsson Mats O., Nielsen Elisabet I., British Journal of Clinical Pharmacology . 2018,第3期

机译：通过建模的白细胞介素-6和C反应蛋白的时间过程预测佐剂化疗后乳腺癌患者的发热中性粒细胞减少症的风险
2. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling [J] . Netterberg Ida, Karlsson Mats O., Nielsen Elisabet I., British Journal of Clinical Pharmacology . 2018,第3期

机译：通过建模的白细胞介素-6和C反应蛋白的时间过程预测佐剂化疗后乳腺癌患者的发热中性粒细胞减少症的风险
3. Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancer [J] . Goyal Ravi K., Tzivelekis Spiros, Rothman Kenneth J., Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2018,第2期

机译：用于利用G-CSF预防的时间趋势以及在早期乳腺癌中接受佐剂化疗的医疗保健人群中发热中性粒细胞率的风险
4. Combined Effects of Ramipril and Carvedilol on Attenuating Interferon-y, Tumor Necrosis Factor-a, Interleukin-6 and C-Reactive Protein, and Improving Failure in Diabetic Patients [C] . S. Tan, L. Tan, L. Berk, International Congress on Coronary Artery Disease . 2003

机译：Ramipril和Carvedilol对衰减干扰素-Y，肿瘤坏死因子-A，白细胞介素-6和C反应蛋白的综合影响，提高糖尿病患者的失效
5. Predicting neutropenia in breast cancer patients undergoing chemotherapy using a 2-stage FOS-3NN model trained on first cycle blood counts. [D] . Shirdel, Elize. 2005

机译：使用经过第一个周期血细胞计数训练的2期FOS-3NN模型预测正在接受化疗的乳腺癌患者的中性粒细胞减少。
6. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling [O] . Ida Netterberg, Mats O. Karlsson, Elisabet I. Nielsen, 2018

机译：白细胞介素-6和C反应蛋白的时程通过模型预测了辅助化疗后乳腺癌患者发热性中性粒细胞减少的风险
7. MP27-08 RISK STRATIFICATION MODEL FOR LYMPHOVASCULAR INVASION, PATHOLOGICAL T STAGE, LYMPH NODE INVOLVEMENT, AND C-REACTIVE PROTEIN PREDICTS HIGH-RISK PATIENTS -WHO ARE CANDIDATE FOR ADJUVANT CHEMOTHERAPY IN UPPER URINARY TRACT UROTHELIAL CANCER [O] . Kazuhiro Nagao, Hideyasu Matsuyama, Kiyohide Fujimoto, 2016

机译：MP27-08淋巴血管侵袭，病理T阶段，淋巴结受累和C反应蛋白的风险分层模型预测高危患者-Who是上泌尿道尿路上皮癌辅助化疗的候选者

The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling

著录项

相似文献

相关主题

期刊订阅